Serum cobalt in children with essential hypertension

American Journal of Human Biology

Volumn 18, Issue 6, 2006, Pages 798-805

  Nicoloff, G ^a   Angelova, M ^a   Christova, L ^a   Nikolov, A ^a   Alexiev, A ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; COBALT; COLLAGEN ANTIBODY; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ANTIBODY; ELASTIN; ELASTIN ANTIBODY; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; BLOOD VESSEL WALL; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION FUNCTION; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; HUMAN; METAL METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANALYSIS OF VARIANCE; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD VESSELS; BULGARIA; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; COBALT; COLLAGEN; COLLAGEN TYPE IV; ELASTIN; EXTRACELLULAR MATRIX; HUMANS; HYPERTENSION;

EID: 33750854918     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.20554     Document Type: Article

References (57)

1. American Academy of Pediatrics Committee on Nutrition. 1998. Cholesterol in childhood. Pediatrics 101:141-146.
2. Bako G, Jacob MP, Fulop T, Foris G, Leovey A, Robert L. 1987. Immunology of elastin: study of anti-elestin peptide antibodies by DOT immunobinding assay. Immunol Lett 15:187-192.
3. Balashova L, Zaitseva N, Teplinskaia L, Koval'chuk L, Gankovskaia L, Obraztsova E, Aronskind M. 2000. Antitela k kollagenu II i IV tipov, faktor nekroza opukholi al'fa i tsirkuliruiushchie immunnye kompleksy v sleze i syvorotke krovi u bol'nykh s razlichnymi stadiiami diabeticheskoi angioretinopatii. Vestn Oftalmol 116:31-34.
4. Baydanoff S, Nicoloff G, Alexiev C. 1987. Age-related changes in anti-elastin antibodies in serum from normal and atherosclerotic human subjects. Atherosclerosis 63: 267-271.
5. Bizbiz L, Bonithon-Kopp C, Ducimetiere P, Berr C, Alperovitch A, Robert L. 1996. Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA Study. Atherosclerosis 120:47-55.
6. Bizbiz L, Alperovitch A, Robert L. 1997. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA Study. Atherosclerosis 131:73-78.
7. Cavun S, Millington WR. 2001. Evidence that hemorrhagic hypotension is mediated by the ventrolateral periaqueductal gray region. Am J Physiol Regul Integr Comp Physiol 281:747-752.
8. Colburn K, Langga-Shariffi E, Kelly G, Malto M, Sandberg L, Baydanoff S, Green L. 2003. Abnormalities of serum antielastin antibodies in connective tissue diseases. J Invest Med 51:104-109.
9. Daskalova M, Taskov H, Dimitrova E, Baydanoff S. 1997. Humoral and cellular immune response to elastin in patients with systemic sclerosis. Autoimmunity 25:233-241.
10. Dugin SF, Zakharova NV, Medvedev OS. 1991. Hemodynamic mechanisms of the hypotensive effect of cobalt in anesthetized rats. Kardiologiia 31:80-82.
11. Dzhuraev KhN, Nasriddinova NN. 1992. Experimental atherosclerosis and its correction with Co-35. Biull Eksp Biol Med 114:256-257.
12. Fulop T, Wei SM, Robert L, Jacob MP. 1990. Determination of elastin peptides in normal and atherosclerotic human sera by ELISA. Clin Physiol Biochem 8:273-282.
13. Gminski J, Drozdz M, Ulfig-Maslanka R, Najda J. 1991. Evaluation of elastin metabolism in children from families with high risk of atherosclerosis. Atherosclerosis 91:185-189.
14. Grahovac Z, Mitic S, Pecev E, Tosic S. 2006. Kinetic spectrophotometric determination of Co(II) ion by the oxidation of Ponceau 4R by hydrogen peroxide. J Serb Chem Soc 71:189-196.
15. Hamby R, Kolatkar N, D'Agostino A. 2004. Heart Center Online. www.heartcenteronline.com. For cardiologists and their patients (pediatric hypertension). Source: adapted from the National Heart Lung and Blood Institutes, Blood Pressure, Tables for Children and Adolescents (May 2004).
16. Hasslacher C, Brocks D, Mann J, Waldherr R. 1987. Influence of hypertension on serum concentration of type IV collagen antigens in streptozotocin-diabetic and non-diabetic rats. Diabetologia 30:344-347.
17. Kajic P, Milosev I, Pihlar B, Pisot V. 2003. Determination of trace cobalt concentrations in human serum by adsorptive stripping voltametry. J Trace Elements Med Biol 17:163-159.
18. Kliorin A. 1981. Atherosclerosis in children. Leningrad: Medicina.
19. Kuhn K. 1994. Basement membrane (TYPE IV) collagen. Matrix Biol 14:439-445.
20. Lim P, Tzemos N, Farquharson C, Anderson J, Deegan P, MacWalter R, Struthers A, MacDonald T. 2002. Reversible hypertension following celiac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction. J Hum Hypertens 16:411-415.
21. Lurie Y. 1971. Spravoshnic po analytisheskoy khimii. Moscow: Khimiya.
22. Marinov M, Angelova M, Alexiev A. 2000. Determination of cobalt in serum by deuterium background corrected atomic absorption spectrometry. In: Lazarov N, editor. Proceedings of the Eighth National Conference on Biomedical Physics and Engineering, Sofia, 12-14 October. Sofia: Medical University-Sofia. p 20-23.
23. Moreland L, Gay R, Gay S. 1991. Collagen autoantibodies in patients with vasculitis and systemic hipus erythematosus. Clin Immunol Immunopathol 60:412-418.
24. Morgan K, Clague R, Collins I, Ayad S, Phinn S, Holt P. 1989. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum 32: 139-145.
25. Mottola H, Perez-Bendito D. 1996. Kinetic determinations and some kinetic aspects of analytical chemistry. Anal Chem 68:257-263.
26. Mujumdar V, Chandra M, Tummalapalli C, Aru G, Tyagi S. 2002. Mechanism of constrictive vascular remodeling by homocisteine: role of PPAR. Am J Physiol Cell Physiol 282:1009-1015.
27. Murray MT. 1996. The encyclopedia of nutritional supplements. Rocklin, CA. Prima Publishing. p 132-136.
28. Nicoloff G, Christova P. 2003. Elastin degradation products among obese children with family history for arterial hypertension. Diabetologia Croatica 32:23-28.
29. Nicoloff G, Petkova M, Baydanoff S. 1998. Serum levels of elastin and collagen-derived peptides in children at a high risk of atherosclerosis. Diabetologia Croatica 27:17-21.
30. Nicoloff G, Baydanoff S, Stanimirova N, Petrova C, Christova P. 2000. An association of anti-elastin IgA antibodies with development of retinopathy in diabetic children. Gen Pharmacol 35:83-87.
31. Nicoloff G, Baydanoff S, Stanimirova N, Petrova C, Christova P. 2001. Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus - longitudinal study. Pediatr Diabetes 2:184-190.
32. Nicoloff G, Baydanoff S, Petrova C, Christova P. 2002. Serum antibodies to collagen type IV and development of diabetic vascular complications in children with type 1 (insulin-dependent) diabetes mellitus - A longitudinal study. Vasc Pharmacol 38:143-147.
33. Nicoloff G, Petrova C, Dimitrova-Laleva P, Christova P. 2003. Increased elastin turnover among obese and diabetic children with vascular complications Diabetologia. Croatica 32:79-82.
34. Nicoloff G, Blazhev A, Petrova C, Christova F, Jordanova-Laleva P, Dekov D, Dorovski P. 2005a. Detection of free anti-elastin antibodies among diabetic children. J Invest Med 53:128-134.
35. Nicoloff G, Nikolov A, Dekov D. 2005b. Serum AGE-elastin derived peptides among diabetic children. Vase Pharmacol 43:193-197.
36. Paulsson M. 1992. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27:93-127.
37. Refsum H, Ueland PM, Nygard O, Vollset SE. 1998. Homocisteine and cardiovascular disease. Annu Rev Med 49: 31-61.
38. Risteli L, Risteh J. 1988. Basement membrane related protein antigens in blood. In: Gulber M, Sternberg M, editors. Progress in basement membrane research. Renal and related aspects in health and disease. London: John Libbey Eurotext Ltd. p 299-308.
39. Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G. 2003. Homocysteine and essential hypertension. J Clin Pharmacol 43:1299-1306.
40. Rosenbloom J, Abrams WR, Mecham R. 1993. Extracellular matrix 4: the elastic fiber. FASEB J 7:1208-1218.
41. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y. 1997. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type TV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 78:505-508.
42. Schuppan D, Riecken E. 1990. Molecules of the extracellular matrix: potential role of collagens and glycoproteins in intestinal adaptation. Digestion 46:2-11.
43. Schuster GS, Caughman GB. 2004. Alterations of cell lipids by metal salts. J Biomed Meter Res A 70:347-353.
44. Siri P, Verhoef P, Kok F. 1998. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr 17:435-441.
45. Sorof J, Daniels S. 2002. Obesity hypertension in children a problem of epidemic proportions. Hypertension 40:441-451.
46. Stangl G, Roth-Maier D, Kirchgessner M. 2000. Vitamin B12 deficiency and hyperhomocysteinemia are partly ameliorated by cobalt and nickel supplementation in pigs. J Nutr 130:3038-3044.
47. 125I-radioimmunoassay. Arthritis Rheum 26:832-840.
48. Tisheva S. 2005a. Changes in elastin degradation immunological indices in patients with moderate arterial hypertension maintained on systematic antihypertension treatment. Biotechnol Biotechnol Equip 19:149-159.
49. Tisheva S. 2005b. Immunological changes in elastin degradation indices in prehypertensive patients. Biotechnol Biotechnol Equip 19:160-165.
50. Todorovska N, Karadjova I, Arpadjan S, Stafilov T. 2003. Electrothermal atomic absorption spectrometric determination of cobalt in human serum and urine. Acta Pharm 53:83-90.
51. Tsalev D. 1995. Atomic absorption spectrometry in ocupational and environmental health practic, volume III, progress in analytical metodology. Boca Raton: CRC Press.
52. Vandecasteele C, Block C. 1993. Modern methods for trace elements determination. Chichester: John Wiley & Sons.
53. Wojakowski W, Tendera M. 2004. Cardiovascular disease prevention - risk assessment and management of children from families with premature coronary heart disease. Biochemical risk markers beyond traditional risk factors. E-J Cardiol Pract 3:7.
54. World Health Organization. 1996. Trace elements in human nutrition and health Report of a WHO expert committee. Geneva: WHO.
55. Yang C, Brinckmann J, Rui H, Vehring Y, Lehmann H, Kekow J, Wolff H, Gross W, Muller P. 1993. Autoantibodies to cartilage collagens in relapsing polychondritis. Dermatol Res 285:245-249.
56. Yano Y, Ura H, Sumida Y, Gabazza EC, Misaki M, Shima T. 1997. Serum 7S domain of type IV collagen levels in essential hypertension and hypertensive type 2 diabetic patients. Diabetes Med 14:466-471.
57. Zervoudaki A, Toutouzas P. 2003. Remodeling of resistance vessels in essential hypertension. Hellenic J Cardiol. 44: 116-124.